0001209191-21-034452.txt : 20210520 0001209191-21-034452.hdr.sgml : 20210520 20210520170021 ACCESSION NUMBER: 0001209191-21-034452 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210518 FILED AS OF DATE: 20210520 DATE AS OF CHANGE: 20210520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Castagna Michael CENTRAL INDEX KEY: 0001674282 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50865 FILM NUMBER: 21945231 MAIL ADDRESS: STREET 1: 25134 RYE CANYON LOOP STREET 2: SUITE 300 CITY: VALENCIA STATE: CA ZIP: 91355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANNKIND CORP CENTRAL INDEX KEY: 0000899460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133607736 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30930 RUSSELL RANCH ROAD STREET 2: SUITE 300 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 BUSINESS PHONE: 818-661-5000 MAIL ADDRESS: STREET 1: 30930 RUSSELL RANCH ROAD STREET 2: SUITE 300 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-18 0 0000899460 MANNKIND CORP MNKD 0001674282 Castagna Michael 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 1 1 0 0 Chief Executive Officer Restricted Stock Unit 2021-05-18 4 A 0 190092 0.00 A 1307652 D Restricted Stock Unit 2021-05-18 4 A 0 226000 0.00 A 1533652 D Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. /s/ Michael Castagna 2021-05-18